Cargando…
Evidence for the High Importance of Co-Morbid Factors in HFE C282Y/H63D Patients Cared by Phlebotomies: Results from an Observational Prospective Study
Despite type I haemochromatosis (HC) is mainly associated with the HFE C282Y/C282Y genotype, a second genotype -C282Y/H63D- has mostly been described in other patients. Its association with HC, apart from any associated co-morbid factors, remains unclear and complex to interpret for physicians. This...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855242/ https://www.ncbi.nlm.nih.gov/pubmed/24339903 http://dx.doi.org/10.1371/journal.pone.0081128 |
_version_ | 1782294905261916160 |
---|---|
author | Saliou, Philippe Le Gac, Gérald Mercier, Anne-Yvonne Chanu, Brigitte Guéguen, Paul Mérour, Marie-Christine Gourlaouen, Isabelle Autret, Sandrine Le Maréchal, Cédric Rouault, Karen Nousbaum, Jean-Baptiste Férec, Claude Scotet, Virginie |
author_facet | Saliou, Philippe Le Gac, Gérald Mercier, Anne-Yvonne Chanu, Brigitte Guéguen, Paul Mérour, Marie-Christine Gourlaouen, Isabelle Autret, Sandrine Le Maréchal, Cédric Rouault, Karen Nousbaum, Jean-Baptiste Férec, Claude Scotet, Virginie |
author_sort | Saliou, Philippe |
collection | PubMed |
description | Despite type I haemochromatosis (HC) is mainly associated with the HFE C282Y/C282Y genotype, a second genotype -C282Y/H63D- has mostly been described in other patients. Its association with HC, apart from any associated co-morbid factors, remains unclear and complex to interpret for physicians. This study assesses the weight of this genotype and the role of co-morbid factors in the occurrence of iron overload. This prospective study included the C282Y/C282Y (n = 172) and C282Y/H63D (n = 58) patients enrolled in a phlebotomy program between 2004 and 2007 in a blood centre of western Brittany (Brest, France), where HC is frequent. We compared prevalence of these two genotypes, as well as patients’ profile regarding degree of iron overload and prevalence of co-morbid factors. First, we confirmed the obvious deficit of C282Y/H63D compound heterozygotes among patients cared by phlebotomies. This genotype was 3.0 times less frequent than the C282Y/C282Y genotype among those patients (18.9% vs. 56.0%) whereas it was 4.9 times more frequent in the general population (4.3% vs. 0.9%; p<0.0001). Despite a similar level of hyperferritinaemia, the C282Y/H63D patients who came to medical attention had a milder plasma iron overload, reflected by a lower transferrin saturation median (52.0% vs. 84.0%; p<0.0001). They also exhibited more frequently co-morbid factors, as heavy drinking (26.0% vs. 13.9%; p = 0.0454), overweight (66.7% vs. 39.4%; p = 0.0005) or both (21.3% vs. 2.6%; p<0.0001). Ultimately, they required a lower amount of iron removed to reach depletion (2.1 vs. 3.4 g; p<0.0001), clearly reflecting their lower tissue iron. This study confirms that H63D is a discrete genetic susceptibility factor whose expression is most visible in association with other co-factors. It highlights the importance of searching for co-morbidities in these diagnostic situations and of providing lifestyle and dietary advice. |
format | Online Article Text |
id | pubmed-3855242 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-38552422013-12-11 Evidence for the High Importance of Co-Morbid Factors in HFE C282Y/H63D Patients Cared by Phlebotomies: Results from an Observational Prospective Study Saliou, Philippe Le Gac, Gérald Mercier, Anne-Yvonne Chanu, Brigitte Guéguen, Paul Mérour, Marie-Christine Gourlaouen, Isabelle Autret, Sandrine Le Maréchal, Cédric Rouault, Karen Nousbaum, Jean-Baptiste Férec, Claude Scotet, Virginie PLoS One Research Article Despite type I haemochromatosis (HC) is mainly associated with the HFE C282Y/C282Y genotype, a second genotype -C282Y/H63D- has mostly been described in other patients. Its association with HC, apart from any associated co-morbid factors, remains unclear and complex to interpret for physicians. This study assesses the weight of this genotype and the role of co-morbid factors in the occurrence of iron overload. This prospective study included the C282Y/C282Y (n = 172) and C282Y/H63D (n = 58) patients enrolled in a phlebotomy program between 2004 and 2007 in a blood centre of western Brittany (Brest, France), where HC is frequent. We compared prevalence of these two genotypes, as well as patients’ profile regarding degree of iron overload and prevalence of co-morbid factors. First, we confirmed the obvious deficit of C282Y/H63D compound heterozygotes among patients cared by phlebotomies. This genotype was 3.0 times less frequent than the C282Y/C282Y genotype among those patients (18.9% vs. 56.0%) whereas it was 4.9 times more frequent in the general population (4.3% vs. 0.9%; p<0.0001). Despite a similar level of hyperferritinaemia, the C282Y/H63D patients who came to medical attention had a milder plasma iron overload, reflected by a lower transferrin saturation median (52.0% vs. 84.0%; p<0.0001). They also exhibited more frequently co-morbid factors, as heavy drinking (26.0% vs. 13.9%; p = 0.0454), overweight (66.7% vs. 39.4%; p = 0.0005) or both (21.3% vs. 2.6%; p<0.0001). Ultimately, they required a lower amount of iron removed to reach depletion (2.1 vs. 3.4 g; p<0.0001), clearly reflecting their lower tissue iron. This study confirms that H63D is a discrete genetic susceptibility factor whose expression is most visible in association with other co-factors. It highlights the importance of searching for co-morbidities in these diagnostic situations and of providing lifestyle and dietary advice. Public Library of Science 2013-12-05 /pmc/articles/PMC3855242/ /pubmed/24339903 http://dx.doi.org/10.1371/journal.pone.0081128 Text en © 2013 Saliou et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Saliou, Philippe Le Gac, Gérald Mercier, Anne-Yvonne Chanu, Brigitte Guéguen, Paul Mérour, Marie-Christine Gourlaouen, Isabelle Autret, Sandrine Le Maréchal, Cédric Rouault, Karen Nousbaum, Jean-Baptiste Férec, Claude Scotet, Virginie Evidence for the High Importance of Co-Morbid Factors in HFE C282Y/H63D Patients Cared by Phlebotomies: Results from an Observational Prospective Study |
title | Evidence for the High Importance of Co-Morbid Factors in HFE C282Y/H63D Patients Cared by Phlebotomies: Results from an Observational Prospective Study |
title_full | Evidence for the High Importance of Co-Morbid Factors in HFE C282Y/H63D Patients Cared by Phlebotomies: Results from an Observational Prospective Study |
title_fullStr | Evidence for the High Importance of Co-Morbid Factors in HFE C282Y/H63D Patients Cared by Phlebotomies: Results from an Observational Prospective Study |
title_full_unstemmed | Evidence for the High Importance of Co-Morbid Factors in HFE C282Y/H63D Patients Cared by Phlebotomies: Results from an Observational Prospective Study |
title_short | Evidence for the High Importance of Co-Morbid Factors in HFE C282Y/H63D Patients Cared by Phlebotomies: Results from an Observational Prospective Study |
title_sort | evidence for the high importance of co-morbid factors in hfe c282y/h63d patients cared by phlebotomies: results from an observational prospective study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855242/ https://www.ncbi.nlm.nih.gov/pubmed/24339903 http://dx.doi.org/10.1371/journal.pone.0081128 |
work_keys_str_mv | AT saliouphilippe evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy AT legacgerald evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy AT mercieranneyvonne evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy AT chanubrigitte evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy AT gueguenpaul evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy AT merourmariechristine evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy AT gourlaouenisabelle evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy AT autretsandrine evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy AT lemarechalcedric evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy AT rouaultkaren evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy AT nousbaumjeanbaptiste evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy AT ferecclaude evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy AT scotetvirginie evidenceforthehighimportanceofcomorbidfactorsinhfec282yh63dpatientscaredbyphlebotomiesresultsfromanobservationalprospectivestudy |